Sun Pharma Q1 Results: Net profit falls 2% to ₹2,022 crore; revenue rises 11% YoY
Sun Pharma’s India formulation sales rose 5.1% to ₹3,560.4 crore. US formulation sales at $471 million were up 12% YoY. US sales accounted for over 33% of total consolidated sales of the company.
Sun Pharmaceutical Industries Ltd on Thursday reported a net profit of ₹2,022.54 crore for the quarter ended June 2023, down 1.86% from ₹2,060.88 crore in the same period last year.